Search results
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe latest development comes after the European Commission approved Bristol Myers Squibb’s Opdivo...
Why Is Bristol Myers Squibb Stock Trading Higher On Friday? - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 6 days agoOn Thursday, the FDA approved Bristol Myers Squibb Co’s BMY Breyanzi (lisocabtagene maraleucel;...
I-Mab and BMS assess givastomig for gastric and oesophageal cancer
Pharmaceutical Technology via Yahoo Finance· 17 hours agoThe US Food and Drug Administration (FDA) awarded orphan drug designation to givastomig to treat...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo Finance· 2 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 1 day agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 10 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 7 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
'Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC
Medscape· 6 days agoFive-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 5 days agoEGFR testing now needed for all patients with stage III disease, experts say
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 2 days agoTeva has a decent pipeline of biosimilars, with some being developed in partnership with Alvotech...